Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
Status:
Withdrawn
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This randomized clinical trial studies metformin hydrochloride in treating patients with
pancreatic cancer that can be removed by surgery. Metformin hydrochloride may stop the growth
of tumor cells by blocking some of the enzymes needed for cell growth.